Page 8 - University Of Southampton Professors Sir Stephen Holgate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from University of southampton professors sir stephen holgate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In University Of Southampton Professors Sir Stephen Holgate Today - Breaking & Trending Today

COVID-19 vaccine shipments speed up ahead of inoculation drive; Delhi schools to reopen for classes 10, 12

cases in India rose to 1,04,95,147 with 15,968 infections being reported in a day, while the recoveries surged to 1,01,29,111, pushing the national recovery rate to 96.51 percent, said the Union health ministry in its morning update.
The toll mounted to 1,51,529 with 202 more deaths and the case fatality rate stands at 1.44 percent, the data updated at 8 am showed.
The ministry said the active caseload has fallen to 2,14, 507 which is the lowest after 197 days, and its share in the total cases has further shrunk to 2.04 percent. The total active cases were 2,15,125 on 30 June, 2020.
Of the 17,817 new recoveries , 81.83 percent were reported from 10 states andUTs. At 4,270,Kerala has reported the maximum number of single day recoveries, followed by Maharashtra with 3,282 new recoveries. Chhattisgarh recorded another 1,207 daily recoveries. ....

Tamil Nadu , United States , West Bengal , Uttar Pradesh , United Kingdom , Port Blair , Andaman And Nicobar Islands , Madhya Pradesh , Andhra Pradesh , Jammu And Kashmir , Visvas Sarang , Arvind Kejriwal , Oxford Astrazeneca Covishield , Donna Davies , N Biren Singh , Sandip Bhosale , Covishield Covaxin , Makeinindia Indiafightscoronapic , Ratko Djukanovic , Manish Sisodia , Johns Hopkin , Johns Hopkins University , Bir Tikendrajit International Airport In Imphal , United Kingdom National Institute For Health Research , Goa Health Services , Drug Administration ,

Synairgen plc: COVID-19 Clinical Programme Update

Synairgen plc: COVID-19 Clinical Programme Update
Phase III trial design adapted which will expedite results
Phase III trial to commence dosing in UK imminently
Southampton, UK - 18 December 2020: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, today announces updates to the Company s Phase III trial design evaluating SNG001 as a treatment for patients with COVID-19 and positive progress on the regulatory path.
Update to Phase III trial (SG018) protocol in COVID-19 patients
Following discussions with the regulatory agencies, the trial has been amended as follows:
Removal of the lower dose arm, thereby reducing the number of patients required to complete the placebo-controlled trial from 900 patients to 610 patients ....

United Kingdom , Olivia Manser , Geoff Nash , Richard Marsden , John Ward , Donna Davies , Duncan Monteith , James Black , Mary Jane Elliott , Ratko Djukanovic , Kate Bannatyne , Freddie Barnfield , Numis Securities Limited Joint Broker , Company Phase , Consilium Strategic Communications Financial Media , National Priority , National Institute For Health Research , University Of Southampton Professors Sir Stephen Holgate , Urgent Public Health , Clinical Programme , Fast Track , National Institute , Health Research , New Drug , Expedited Regulatory Pathway , Investigational New Drug ,

COVID-19 Clinical Programme Update – IT Business Net

COVID-19 Clinical Programme Update – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Olivia Manser , Geoff Nash , Richard Marsden , John Ward , Donna Davies , Duncan Monteith , James Black , Mary Jane Elliott , Ratko Djukanovic , Kate Bannatyne , Freddie Barnfield , Numis Securities Limited Joint Broker , Company Phase , Consilium Strategic Communications Financial Media , National Priority , National Institute For Health Research , University Of Southampton Professors Sir Stephen Holgate , Urgent Public Health , Clinical Programme , Fast Track , National Institute , Health Research , New Drug , Expedited Regulatory Pathway , Investigational New Drug ,